Shukra Pharmaceuticals Limited
SHUKRAPHAR · NSE · ₹62 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Shukra Pharmaceuticals Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Filing timeline — what the company told the exchange
- Shareholders meeting. Shukra Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed th…
29 Sep 2026 · document
- Shukra Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 28, 2026.…
28 Sep 2026 · document
- Shukra Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201…
24 Sep 2026 · document
- Record Date. Shukra Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 21-Sep-2026.…
18 Sep 2026 · document
- Shareholders meeting. Shukra Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026…
05 Sep 2026 · document
- Shukra Pharmaceuticals Limited has informed the Exchange about General Updates…
03 Sep 2026 · document
- Shukra Pharmaceuticals Limited has informed the Exchange about General Updates…
03 Sep 2026 · document
- Shukra Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.…
02 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time